Back to Search
Start Over
Novartis medication reduces early-stage breast cancer recurrence by 25%
- Source :
- Plus Company Updates. June 2, 2023
- Publication Year :
- 2023
-
Abstract
- Novartis breast cancer drug Kisqali cut the risk of recurrence by 25% in early-stage breast cancer, positioning the Swiss drugmaker to win new patients and challenge strong rival Eli Lilly. [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.755545688